Reuters logo
BRIEF-Novartis says drug combination Tafinlar + Mekinist receives EU approval
April 3, 2017 / 5:20 AM / 8 months ago

BRIEF-Novartis says drug combination Tafinlar + Mekinist receives EU approval

April 3 (Reuters) - Novartis Ag

* Novartis drug combination Tafinlar + Mekinist receives EU approval for BRAF v600-positive advanced non-small cell lung cancer (NSCLC) Source text for Eikon: [here ] Further company coverage: (Reporting by Zurich Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below